These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 4558539

  • 1. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.
    Goldman JN, Ruddy S, Austen KF.
    J Immunol; 1972 Aug; 109(2):353-9. PubMed ID: 4558539
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
    McLeod B, Lint TF, Baker P, Behrends C, Gewurz H.
    Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
    [Abstract] [Full Text] [Related]

  • 4. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
    McLeod B, Baker P, Gewurz H.
    Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
    [Abstract] [Full Text] [Related]

  • 5. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
    McLeod B, Baker P, Behrends C, Gewurz H.
    Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the terminal stage of complement-mediated lysis (reactive lysis) by zinc and copper ions.
    Yamamoto K, Takahashi M.
    Int Arch Allergy Appl Immunol; 1975 Feb; 48(5):653-63. PubMed ID: 1169223
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.
    Baker PJ, Osofsky SG.
    Clin Exp Immunol; 1981 Mar; 43(3):549-56. PubMed ID: 6912799
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of C4-synthesizing cells from guinea-pig spleen.
    Ilgen CL, Bossen EH, Rowlands DT, Burkholder PM.
    Immunology; 1974 Mar; 26(3):659-65. PubMed ID: 4604643
    [Abstract] [Full Text] [Related]

  • 15. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
    Baker PJ, Lint TF, McLeod BC, Behrends CL, Gewurz H.
    J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
    [Abstract] [Full Text] [Related]

  • 16. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.
    Lachmann PJ, Kay AB, Thompson RA.
    Immunology; 1970 Dec; 19(6):895-9. PubMed ID: 5487541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW, Shin ML.
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.